Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

REPAGLINIDE PHARMACOKINETICS PATHWAY (PW:0000726)

View Ontology Report

Description

Repaglinide is an anti-diabetic drug used as a blocker of the ATP-sensitive potassium channels (KATP) to promote insulin secretion and lower blood glucose levels in patients with type 2 diabetes mellitus (T2D). In response to elevated levels of circulating glucose; insulin is secreted from the pancreatic beta cells. This effect is counteracted by glucagon when the glucose levels are low - the two hormones act to maintain glucose homeostasis. The secre

Pathway Diagram:

Ariadne Genomics Inc. uptaken repaglinide CYP3A4 ---> repaglinide metabolites repaglinide metabolites ---> repaglinide and metabolites excretion repaglinide repaglinide ---> uptaken repaglinide repaglinide and metabolites excretion repaglinide metabolites CYP2C8 ---> repaglinide metabolites CYP3A4 SLCO1B1 CYP2C8
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
repaglinide pharmacokinetics pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 ISO RGD PMID:17253883 RGD:2316509
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 ISO RGD PMID:17253883 RGD:2316509 NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
JBrowse link

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Small Moleculerepagliniderepaglinide

Pathway Gene Annotations

Disease Annotations Associated with Genes in the repaglinide pharmacokinetics pathway
Pathway Annotations Associated with Genes in the repaglinide pharmacokinetics pathway
Pathway TermsGene Symbols
acetylsalicylic acid pharmacodynamics pathwayCyp2c79
antipyrine drug pathwayCyp2c79
arachidonic acid metabolic pathwayCyp2c79
artemether pharmacokinetics pathwayCyp3a2
axitinib pharmacokinetics pathwayCyp3a2
caffeine pharmacokinetics pathwayCyp2c79 , Cyp3a2
carbamazepine pharmacokinetics pathwayCyp2c79 , Cyp3a2
celecoxib pharmacodynamics pathwayCyp2c79 , Cyp3a2
celecoxib pharmacokinetics pathwayCyp3a2
clomipramine pharmacokinetics pathwayCyp3a2
clopidogrel pharmacodynamics pathwayCyp3a2
clopidogrel pharmacokinetics pathwayCyp3a2
codeine and morphine pharmacodynamics pathwayCyp3a2
codeine and morphine pharmacokinetics pathwayCyp3a2
cyclophosphamide pharmacodynamics pathwayCyp2c79 , Cyp3a2
cyclophosphamide pharmacokinetics pathwayCyp2c79 , Cyp3a2
diclofenac pharmacodynamics pathwayCyp2c79
diflunisal pharmacodynamics pathwayCyp2c79
doxepin pharmacokinetics pathwayCyp3a2
etodolac pharmacodynamics pathwayCyp2c79
etoposide pharmacodynamics pathwayCyp3a2
etoposide pharmacokinetics pathwayCyp3a2
felbamate pharmacokinetics pathwayCyp3a2
fenoprofen pharmacodynamics pathwayCyp2c79
fluoxetine pharmacodynamics pathwayCyp3a2
fluoxetine pharmacokinetics pathwayCyp3a2
flurbiprofen pharmacodynamics pathwayCyp2c79
gefitinib pharmacokinetics pathwayCyp3a2
ibuprofen pharmacodynamics pathwayCyp2c79 , Cyp3a2
ibuprofen pharmacokinetics pathwayCyp2c79 , Cyp3a2
ifosfamide pharmacodynamics pathwayCyp2c79 , Cyp3a2
ifosfamide pharmacokinetics pathwayCyp2c79 , Cyp3a2
imipramine pharmacodynamics pathwayCyp3a2
imipramine pharmacokinetics pathwayCyp3a2
indometacin pharmacodynamics pathwayCyp2c79
indometacin pharmacodynamics pathwayCyp2c79
irinotecan pharmacodynamics pathwayCyp3a2
irinotecan pharmacokinetics pathwayCyp3a2
ketoprofen pharmacodynamics pathwayCyp2c79
ketorolac pharmacodynamics pathwayCyp2c79
leukotriene C4 synthase deficiency pathwayCyp2c79
lidocaine pharmacodynamics pathwayCyp3a2
lidocaine pharmacokinetics pathwayCyp3a2
linoleic acid metabolic pathwayCyp3a2
lornoxicam pharmacodynamics pathwayCyp2c79
losartan pharmacokinetics pathwayCyp2c79 , Cyp3a2
magnesium salicylate pharmacodynamics pathwayCyp2c79
mefenamic acid pharmacodynamics pathwayCyp2c79
meloxicam pharmacodynamics pathwayCyp2c79
methadone pharmacodynamics pathwayCyp2c79 , Cyp3a2
methadone pharmacokinetics pathwayCyp2c79 , Cyp3a2
mycophenolic acid pharmacokinetics pathwayCyp2c79 , Cyp3a2
nabumetone pharmacodynamics pathwayCyp2c79
naproxen pharmacodynamics pathwayCyp2c79
nateglinide pharmacokinetics pathwayCyp3a2
neviparine pharmacokinetics pathwayCyp3a2
paracetamol drug pathwayCyp2c79
paracetamol pharmacokinetics pathwayCyp3a2
phase I biotransformation pathway via cytochrome P450Cyp3a2
phenytoin pharmacodynamics pathwayCyp3a2
piroxicam pharmacodynamics pathwayCyp2c79
prednisone pharmacodynamics pathwayCyp3a2
prednisone pharmacokinetics pathwayCyp3a2
repaglinide pharmacokinetics pathwayCyp2c79 , Cyp3a2
retinol metabolic pathwayCyp3a2
rosiglitazone pharmacokinetics pathwayCyp2c79
salicylic acid pharmacodynamics pathwayCyp2c79
sodium salicylate pharmacodynamics pathwayCyp2c79
sorafenib pharmacokinetics pathwayCyp2c79 , Cyp3a2
statin pharmacokinetics pathwayCyp2c79 , Cyp3a2
steroid hormone biosynthetic pathwayCyp3a2
sulindac pharmacodynamics pathwayCyp2c79
tamoxifen pharmacodynamics pathwayCyp3a2
tamoxifen pharmacokinetics pathwayCyp2c79 , Cyp3a2
teniposide pharmacodynamics pathwayCyp3a2
teniposide pharmacokinetics pathwayCyp3a2
tenoxicam pharmacodynamics pathwayCyp2c79
tiaprofenic acid pharmacodynamics pathwayCyp2c79
tolmetin pharmacodynamics pathwayCyp2c79
tramadol pharmacokinetics pathwayCyp3a2
valdecoxib pharmacodynamics pathwayCyp2c79
venlafaxine pharmacokinetics pathwayCyp3a2
vinblastine pharmacodynamics pathwayCyp3a2
vinorelbine pharmacodynamics pathwayCyp3a2
vitamin A deficiency pathwayCyp3a2
warfarin pharmacokinetics pathwayCyp2c79 , Cyp3a2

References Associated with the repaglinide pharmacokinetics pathway:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: